Litcius/Paper detail

Accuracy of <sup>68</sup>Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer.

Maija Radziņa, Māra Tirane, Lilita Roznere, Liene Zemniece, Laura Dronka, Marika Kalniņa, Edgars Mamis, J. Biederer, V. Lietuvietis, A. Freimanis, Egils Vjaters

2020PubMed44 citationsOpen Access PDF

Abstract

Ga-PSMA-11 PET/CT, MRI and bone scintigraphy. According to the histopathologically or clinically defined reference standard all results were classified as true positive, false positive, true negative or false negative. Local recurrence was present in 11/32 patients, lymph node metastases - in 13/32 patients and, bone metastases - in 6/32 patients. Against the standard of reference, sensitivity, specificity and accuracy for local recurrence of PET/CT were 63.6 %; 73.7%; 77.8%, respectively. MRI reached 90.9%; 94.7%; 92.3%, respectively. For local lymph node metastases PET/CT - 83.3%; 80.0% and 90.6%, respectively. MRI - 41.7%; 94.4%; 72.0%, respectively. For evaluation of bone metastases in PET/CT - 83.3%; 92.0%; 71.0%, respectively. Bone scintigraphy - 50.0%; 84.0%; 77.4%, respectively. In conclusion, mpMRI offered the better diagnostic accuracy in the detection of local recurrence and while PSMA PET/CT was superior in the detection of distant and lymph node metastases.

Topics & Concepts

MedicineProstate cancerLymph nodeBone scintigraphyRadiologyMagnetic resonance imagingNuclear medicineBiochemical recurrencePositron emission tomographyPET-CTCancerPathologyProstatectomyInternal medicineProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment
Accuracy of <sup>68</sup>Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer. | Litcius